PHARMA JACK: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMA JACK
Largest movements
- Receivables within one year +€32,589
up €32,589 (+28.2%), from €115,720 to €148,309
of which Trade receivables: +€32,797
- Tangible fixed assets -€25,786
down €25,786 (-11.5%), from €223,704 to €197,919
of which Land and buildings: -€27,125
- Cash -€8,819
down €8,819 (-8.2%), from €107,563 to €98,744
mainly Contributions, distributions and other (-€76,368) and Debts after one year (-€34,794)
- Profit (loss) carried forward -€68,308
no longer reported in 2025 (was €68,308)
- Other debts +€64,460
up €64,460 (+317.0%), from €20,334 to €84,795
- Reserves +€48,460
up €48,460 (+696.3%), from €6,959 to €55,419
- Debts after one year -€34,794
down €34,794 (-12.8%), from €271,004 to €236,210
- Trade debts -€9,342
down €9,342 (-7.3%), from €128,745 to €119,403
- Gross operating margin +€76,194
up €76,194 (+25.4%), from €299,793 to €375,987
- Taxes +€17,063
up €17,063 (+313.8%), from €5,438 to €22,501
- Staff costs +€12,600
up €12,600 (+5.3%), from €236,469 to €249,068
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €606,935 | €604,334 | -€2,600 | -0.4% |
| Fixed assets | 21/28 | €223,704 | €197,919 | -€25,786 | -11.5% |
| Tangible fixed assets | 22/27 | €223,704 | €197,919 | -€25,786 | -11.5% |
| Land and buildings | 22 | €162,849 | €135,725 | -€27,125 | -16.7% |
| Plant, machinery and equipment | 23 | €12,228 | €23,997 | +€11,769 | +96.2% |
| Furniture and vehicles | 24 | €13,642 | €10,803 | -€2,840 | -20.8% |
| Leasing and similar rights | 25 | €34,985 | €27,395 | -€7,590 | -21.7% |
| Current assets | 29/58 | €383,230 | €406,416 | +€23,185 | +6.0% |
| Stocks and contracts in progress | 3 | €157,523 | €158,885 | +€1,361 | +0.9% |
| Stocks | 30/36 | €157,523 | €158,885 | +€1,361 | +0.9% |
| Amounts receivable within one year | 40/41 | €115,720 | €148,309 | +€32,589 | +28.2% |
| Trade receivables | 40 | €95,383 | €128,180 | +€32,797 | +34.4% |
| Other amounts receivable | 41 | €20,337 | €20,128 | -€208 | -1.0% |
| Cash at bank and in hand | 54/58 | €107,563 | €98,744 | -€8,819 | -8.2% |
| Deferred charges and accrued income | 490/1 | €2,424 | €478 | -€1,946 | -80.3% |
| Total equity and liabilities | 10/49 | €606,935 | €604,334 | -€2,600 | -0.4% |
| Equity | 10/15 | €81,567 | €55,519 | -€26,048 | -31.9% |
| Contributions | 10/11 | €6,300 | €100 | -€6,200 | -98.4% |
| Reserves | 13 | €6,959 | €55,419 | +€48,460 | +696.3% |
| Distributable reserves | 133 | €6,959 | €55,419 | +€48,460 | +696.3% |
| Profit (loss) carried forward | 14 | €68,308 | - | -€68,308 | |
| Amounts payable | 17/49 | €525,367 | €548,815 | +€23,448 | +4.5% |
| Amounts payable after more than one year | 17 | €271,004 | €236,210 | -€34,794 | -12.8% |
| Financial debts | 170/4 | €271,004 | €236,210 | -€34,794 | -12.8% |
| Amounts payable within one year | 42/48 | €251,077 | €309,880 | +€58,803 | +23.4% |
| Current portion of amounts payable after more than one year | 42 | €38,336 | €34,702 | -€3,634 | -9.5% |
| Trade debts | 44 | €128,745 | €119,403 | -€9,342 | -7.3% |
| Suppliers | 440/4 | €128,745 | €119,403 | -€9,342 | -7.3% |
| Taxes, remuneration and social security | 45 | €63,662 | €70,980 | +€7,317 | +11.5% |
| Taxes | 450/3 | €13,513 | €31,195 | +€17,683 | +130.9% |
| Remuneration and social security | 454/9 | €50,150 | €39,784 | -€10,365 | -20.7% |
| Other amounts payable | 47/48 | €20,334 | €84,795 | +€64,460 | +317.0% |
| Accrued charges and deferred income | 492/3 | €3,286 | €2,726 | -€561 | -17.1% |
| Remuneration, social security and pensions | 62 | €236,469 | €249,068 | +€12,600 | +5.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €37,945 | €40,098 | +€2,152 | +5.7% |
| Other operating charges | 640/8 | €3,078 | €593 | -€2,485 | -80.7% |
| Gross operating margin | 9900 | €299,793 | €375,987 | +€76,194 | +25.4% |
| Operating profit (loss) | 9901 | €22,301 | €86,229 | +€63,927 | +286.7% |
| Financial income | 75/76B | €224 | €206 | -€18 | -8.0% |
| Recurring financial income | 75 | €224 | €206 | -€18 | -8.0% |
| Financial charges | 65/66B | €11,988 | €13,614 | +€1,625 | +13.6% |
| Recurring financial charges | 65 | €11,988 | €13,614 | +€1,625 | +13.6% |
| Profit (loss) for the period before taxes | 9903 | €10,537 | €72,821 | +€62,284 | +591.1% |
| Income taxes | 67/77 | €5,438 | €22,501 | +€17,063 | +313.8% |
| Profit (loss) for the period | 9904 | €5,099 | €50,320 | +€45,221 | +886.8% |
| Profit (loss) for the period to be appropriated | 9905 | €5,099 | €50,320 | +€45,221 | +886.8% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.